Styrene

Styrene

SCHEMBL17065130

C=C(CCCC)C(=O)O.C=Cc1ccccc1.C=Cc1ccccc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
ALDH1A1 P00352 3/20 0.47
TSHR P16473 1/20 0.47
TDP1 Q9NUW8 1/20 0.46
CES2 O00748 3/20 0.45
CES1 P23141 3/20 0.45
HDAC3 O15379 2/20 0.43
EGFR P00533 1/20 0.40
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
RECQL P46063 1/20 0.39
KMT2A Q03164 1/20 0.39
PTGS2 P35354 1/20 0.39
PTGES O14684 1/20 0.39
ALOX5 P09917 1/20 0.39
PPARG P37231 1/20 0.39
AKR1C3 P42330 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38
ELANE P08246 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Styrene SCHEMBL5270544 1.00 LMNA (0.47) LMNAALDH1A1TSHRTDP1CES2
Styrene SCHEMBL258132 1.00 LMNA (0.47) LMNAALDH1A1TSHRTDP1CES2
Styrene SCHEMBL987788 0.95 LMNA (0.44) LMNAALDH1A1TSHRTDP1CES2
Styrene SCHEMBL7783115 0.95 LMNA (0.44) LMNAALDH1A1TSHRTDP1CES2
Styrene SCHEMBL3430407 0.95 LMNA (0.44) LMNAALDH1A1TSHRTDP1CES2
Styrene SCHEMBL1628229 0.95 LMNA (0.54) LMNAALDH1A1TSHRTDP1CES2
Styrene SCHEMBL4407755 0.94 LMNA (0.43) LMNAALDH1A1TSHRTDP1CES2
Styrene SCHEMBL14563189 0.94 LMNA (0.43) LMNAALDH1A1TSHRTDP1CES2
Styrene SCHEMBL8350505 0.94 TDP1 (0.55) LMNAALDH1A1TSHRTDP1CES2
Styrene SCHEMBL905411 0.94 TDP1 (0.55) LMNAALDH1A1TSHRTDP1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170015762-A1 CONTROLLED RADICAL POLYMERIZATION BASF SE (DE) 2017-01-19 US disclosed
EP-3114150-A1 CONTROLLED RADICAL POLYMERIZATION BASF SE (DE) 2017-01-11 EP disclosed
WO-2015134591-A1 CONTROLLED RADICAL POLYMERIZATION BASF SE (DE) 2015-09-11 WO disclosed
US-8980824-B2 Tubulysin compounds, methods of making and use BRISTOL-MYERS SQUIBB COMPANY (US) 2015-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170015762-A1 CONTROLLED RADICAL POLYMERIZATION GLO1, TET1, RIOX2 LMNA 3944/4885ALDH1A1 235/4885TSHR 4673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.